| scholarly article | Q13442814 |
| P50 | author | Parameswaran Hari | Q42118262 |
| P2093 | author name string | William R Drobyski | |
| Robert Frank Cornell | |||
| P2860 | cites work | Induction of graft-versus-host disease after autologous bone marrow transplantation. | Q54355574 |
| Autologous GVHD following PBSCT, with evidence for a graft-versus-myeloma effect | Q64019055 | ||
| Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets | Q68091385 | ||
| Effects of cyclosporine A on T cell development and clonal deletion | Q68097628 | ||
| Graft-versus-leukemia in the rat--the antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease | Q68940313 | ||
| The graft versus host reaction in man after bone marrow transplantation: pathology, pathogenesis, clinical features, and implication | Q70057725 | ||
| Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy | Q71250725 | ||
| Marrow engraftment and clinical manifestations of capillary leak syndrome | Q71592644 | ||
| Cyclosporine-Induced Syngeneic Graft-vs-Host Disease: Prevention of Autoaggression by Treatment with Monoclonal Antibodies to T Lymphocyte Cell Surface Determinants and to MHC Class II Antigens | Q72106278 | ||
| Phase I study of alpha-interferon augmentation of cyclosporine-induced graft versus host disease in recipients of autologous bone marrow transplantation | Q72116768 | ||
| Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression | Q72133091 | ||
| Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemia | Q72656524 | ||
| Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue | Q73117372 | ||
| Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptide | Q73128557 | ||
| Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications | Q74173324 | ||
| Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation | Q74492531 | ||
| Engraftment syndrome after hematopoietic stem cell transplantation in multiple myeloma | Q79206227 | ||
| Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies | Q79920986 | ||
| Severe intestinal graft-versus-host disease following autologous stem cell transplantation | Q80130660 | ||
| Serial measurement of serum C-reactive protein levels can identify patients at risk for severe complications following autologous stem cell transplantation | Q81018139 | ||
| Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma | Q81909390 | ||
| Post-autologous hematopoietic SCT engraftment syndrome: a single center experience | Q83885727 | ||
| A case of severe cutaneous, GI and liver GVHD in a patient with multiple myeloma, status-post-second auto-SCT | Q84217950 | ||
| Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma | Q87012378 | ||
| Acute graft-versus-host disease in recipients of bone-marrow transplants from identical twin donors | Q33498770 | ||
| Increased frequency of autoaggression syndrome associated with autologous stem cell transplantation in breast cancer patients | Q33499065 | ||
| Current issues in chronic graft-versus-host disease | Q33917187 | ||
| Engraftment syndrome following hematopoietic stem cell transplantation | Q34298239 | ||
| Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial. | Q35598758 | ||
| The role of cytokines in graft-versus-host reactions and disease | Q35781650 | ||
| High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT | Q35849935 | ||
| Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution | Q36347989 | ||
| Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity | Q36355418 | ||
| Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma. | Q36503248 | ||
| Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome | Q36575315 | ||
| Pathology of graft-versus-host disease in the gastrointestinal tract | Q37518315 | ||
| Possible role of engraftment syndrome and autologous graft-versus-host disease in myelodysplastic syndrome after autologous stem cell transplantations: retrospective analysis and review of the literature | Q37725459 | ||
| Engraftment syndrome: double-edged sword of hematopoietic cell transplants | Q38315390 | ||
| Abnormalities of Immunoregulatory T Cells in Disorders of Immune Function | Q39897007 | ||
| The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells. | Q39916867 | ||
| Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis | Q40306199 | ||
| Cyclophosphamide and prednisone induction followed by cyclophosphamide mobilization effectively decreases the incidence of engraftment syndrome in patients with POEMS syndrome who undergo stem cell transplantation | Q40316289 | ||
| Skin biopsy in allogeneic and autologous bone marrow transplant patients: a histologic and immunohistochemical study and review of the literature. | Q40514467 | ||
| Engraftment syndrome emerges as the main cause of transplant-related mortality in pediatric patients receiving autologous peripheral blood progenitor cell transplantation | Q40528940 | ||
| CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients | Q40563039 | ||
| Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria | Q40563612 | ||
| Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF). | Q40564199 | ||
| Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival | Q40596090 | ||
| An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose | Q40624714 | ||
| Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation. | Q40661944 | ||
| Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation | Q40683151 | ||
| Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center | Q43198285 | ||
| Autologous graft-versus-host disease | Q44305930 | ||
| Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation | Q44647598 | ||
| Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases | Q44897853 | ||
| Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome | Q46916861 | ||
| Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer | Q47238578 | ||
| Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer | Q47266911 | ||
| Elafin: a possible new biomarker and immunohistochemical stain for pre-engraftment syndrome | Q47984037 | ||
| Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor. | Q51982448 | ||
| Autologous GVHD? | Q53029825 | ||
| Spontaneous autologous graft-versus-host disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts. | Q53258645 | ||
| Engraftment syndrome, the Emperor's new clothes and the artist formerly known as Prince. | Q53628837 | ||
| Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets. | Q54348505 | ||
| P433 | issue | 12 | |
| P921 | main subject | management approach | Q123744924 |
| P304 | page(s) | 2061-2068 | |
| P577 | publication date | 2015-08-29 | |
| P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
| P1476 | title | Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach | |
| P478 | volume | 21 |
| Q40551437 | A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning |
| Q91777235 | A clinical approach to respiratory disease in patients with hematological malignancy, with a focus on respiratory infection |
| Q52670992 | Autologous Graft-Versus-Host Disease of the Gastrointestinal Tract in Patients With Multiple Myeloma and Hematopoietic Stem Cell Transplantation. |
| Q90245997 | Baseline immune dysregulation in autologous stem cell transplant recipients is associated with a 'graft versus host'-like syndrome and poor outcomes |
| Q91865060 | Central nervous system immune reconstitution inflammatory syndrome after autologous stem cell transplantation |
| Q91062663 | Common and critical inflammatory dermatoses every pathologist should know |
| Q95567275 | Early and Acute Complications and the Principles of HSCT Nursing Care |
| Q96306763 | Engraftment Syndrome and Acute Graft-versus-Host Disease: A Meta-Analysis |
| Q64054712 | Graft-versus-host disease in a child with neuroblastoma after autologous stem cell transplantation |
| Q88506851 | Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation |
| Q47714833 | Noninfectious Acute Lung Injury Syndromes Early After Hematopoietic Stem Cell Transplantation |
| Q47678205 | Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation |
| Q28078381 | Pre-engraftment syndrome: clinical significance and pathophysiology |
| Q104064700 | Prior anti-PD-1 therapy as a risk factor for life-threatening peri-engraftment respiratory distress syndrome in patients undergoing autologous stem cell transplantation |
| Q99730640 | Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation |
| Q40361692 | Viral encephalitis after haplo-identical hematopoietic stem cell transplantation: Causative viral spectrum, characteristics, and risk factors. |
Search more.